Market Cap | 81.11M | P/E | 9.83 | EPS this Y | - | Ern Qtrly Grth | -83.00% |
Income | 3.61M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -5.00% |
Sales | 51.71M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 16.00% |
Dividend | N/A | Price/Book | 1.99 | EPS next 5Y | - | 52W High Chg | -15.00% |
Recommedations | - | Quick Ratio | 1.73 | Shares Outstanding | 191.86M | 52W Low Chg | 79.00% |
Insider Own | 45.13% | ROA | 5.19% | Shares Float | 131.20M | Beta | 0.71 |
Inst Own | 6.38% | ROE | 8.29% | Shares Shorted/Prior | -/- | Price | 0.39 |
Gross Margin | 24.34% | Profit Margin | 6.98% | Avg. Volume | 10,282 | Target Price | - |
Oper. Margin | 4.39% | Earnings Date | Sep 20 | Volume | 484 | Change | 0.00% |
Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in the United States and the United Kingdom. The company offers halogen chemicals, disinfectants, electronic specialty gases, sanitizers, heat stabilizers, preservatives, and specialty intermediates, as well as animal health, mineral separation, and odor control products. Its products are used by the electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, and nylon markets. The company markets its products under the IOflo and IOprill brand names. Iofina plc was incorporated in 2005 and is based in London, the United Kingdom.